Lineage Cell Therapeutics In shares owned by Geode Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Lineage Cell Therapeutics In by Geode Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $3.3M | 3.7M | 0.91 |
2024-06-30 | $3.6M | 3.6M | 1.00 |
2024-03-31 | $4.8M | 3.3M | 1.48 |
2023-09-30 | $3.3M | 2.8M | 1.18 |
2023-06-30 | $3.4M | 2.4M | 1.41 |
2023-03-31 | $1.9M | 1.3M | 1.50 |
2022-12-31 | $1.5M | 1.3M | 1.17 |
2022-09-30 | $1.4M | 1.3M | 1.13 |
2022-06-30 | $2.0M | 1.2M | 1.58 |
2022-03-31 | $3.5M | 2.3M | 1.54 |
2021-12-31 | $5.7M | 2.3M | 2.45 |
2021-09-30 | $5.9M | 2.3M | 2.52 |
2021-06-30 | $6.7M | 2.3M | 2.85 |
2021-03-31 | $3.0M | 1.3M | 2.35 |
2020-12-31 | $1.9M | 1.1M | 1.76 |
2020-09-30 | $956k | 1.0M | 0.94 |
2020-06-30 | $888k | 1.0M | 0.87 |
2020-03-31 | $1.4M | 1.7M | 0.83 |
2019-12-31 | $1.4M | 1.6M | 0.89 |
2019-09-30 | $1.5M | 1.5M | 0.98 |